| Mr Jay Douglas Albert Schindler, RPT | |
|
2855 Campus Dr, Suite 650, Plymouth, MN 55441-2649 | |
| (763) 520-1240 | |
| Not Available |
| Full Name | Mr Jay Douglas Albert Schindler |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 22 Years |
| Location | 2855 Campus Dr, Plymouth, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164641924 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 7005 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Infinite Health Collaborative Pa | 1052225042 | 772 |
News Archive
Lumbar spine fractures in a majority of patients with trauma can be detected by routine trauma abdomen and pelvis CT compared to plain radiographs, according to a recent study conducted by radiologists at the University of Cincinnati in Cincinnati, OH.
Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.
A recent study by the RN Work Project found that newly licensed registered nurses (NLRNs) who were verbally abused by nursing colleagues reported lower job satisfaction, unfavorable perceptions of their work environment, and greater intent to leave their current jobs.
Nanotherapeutics, Inc., a privately held specialty biopharmaceutical company, announced today that it had acquired certain assets from DelSite (formerly Carrington Laboratories, Inc.) out of Chapter 7 bankruptcy proceedings in the U.S. Bankruptcy Court for the Northern District of Texas, Dallas Division.
Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology - demonstrate that the Resolute drug-eluting stent from Medtronic, Inc., provides a positive and persistent treatment effect for a wide variety of patients with coronary artery disease.
› Verified 3 days ago
| Provider Name | Infinite Health Collaborative Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1164474250 PECOS PAC ID: 1052225042 Enrollment ID: O20040209000574 |
News Archive
Lumbar spine fractures in a majority of patients with trauma can be detected by routine trauma abdomen and pelvis CT compared to plain radiographs, according to a recent study conducted by radiologists at the University of Cincinnati in Cincinnati, OH.
Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.
A recent study by the RN Work Project found that newly licensed registered nurses (NLRNs) who were verbally abused by nursing colleagues reported lower job satisfaction, unfavorable perceptions of their work environment, and greater intent to leave their current jobs.
Nanotherapeutics, Inc., a privately held specialty biopharmaceutical company, announced today that it had acquired certain assets from DelSite (formerly Carrington Laboratories, Inc.) out of Chapter 7 bankruptcy proceedings in the U.S. Bankruptcy Court for the Northern District of Texas, Dallas Division.
Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology - demonstrate that the Resolute drug-eluting stent from Medtronic, Inc., provides a positive and persistent treatment effect for a wide variety of patients with coronary artery disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jay Douglas Albert Schindler, RPT 6465 Wayzata Blvd, Suite 900, St Louis Park, MN 55426-1728 Ph: (952) 512-5600 | Mr Jay Douglas Albert Schindler, RPT 2855 Campus Dr, Suite 650, Plymouth, MN 55441-2649 Ph: (763) 520-1240 |
News Archive
Lumbar spine fractures in a majority of patients with trauma can be detected by routine trauma abdomen and pelvis CT compared to plain radiographs, according to a recent study conducted by radiologists at the University of Cincinnati in Cincinnati, OH.
Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.
A recent study by the RN Work Project found that newly licensed registered nurses (NLRNs) who were verbally abused by nursing colleagues reported lower job satisfaction, unfavorable perceptions of their work environment, and greater intent to leave their current jobs.
Nanotherapeutics, Inc., a privately held specialty biopharmaceutical company, announced today that it had acquired certain assets from DelSite (formerly Carrington Laboratories, Inc.) out of Chapter 7 bankruptcy proceedings in the U.S. Bankruptcy Court for the Northern District of Texas, Dallas Division.
Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology - demonstrate that the Resolute drug-eluting stent from Medtronic, Inc., provides a positive and persistent treatment effect for a wide variety of patients with coronary artery disease.
› Verified 3 days ago
Paul Julius Solie, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 14100 Carlson Pkwy Ste 200, Plymouth, MN 55441 Phone: 763-519-7900 Fax: 763-450-0202 | |
Alda L Lisk, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5385 Orchid Ln N, Plymouth, MN 55446 Phone: 612-860-1954 | |
Ibackcheck Sports Rehab Physical Therapist Medicare: Medicare Enrolled Practice Location: 2530 Xenium Ln N, Suite 200, Plymouth, MN 55441 Phone: 763-634-8500 | |
Megan Smith-cannistraci, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3025 Harbor Ln N, Suite 314, Plymouth, MN 55447 Phone: 763-559-0356 Fax: 763-559-5193 | |
Sarah Mugge, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4155 County Road 101 N, 2nd Floor, Plymouth, MN 55446 Phone: 952-993-8999 Fax: 952-993-8242 | |
Ms. Katie Jean Ohm, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3401 E Medicine Lake Blvd, Plymouth, MN 55441 Phone: 763-559-3123 | |
Lindsey J Soltvedt, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 14100 Carlson Pkwy Ste 200, Plymouth, MN 55441 Phone: 763-519-7900 Fax: 763-450-0202 |